Evidence map›Paper›PMID 35162062›Full record

ArticleInternational journal of environmental research and public health2022

Risk Factors for Multidrug-Resistant Gram-Negative Bacteria Carriage upon Admission to the Intensive Care Unit.

Nicolás Francisco Fernández-Martínez, Sheila Cárcel-Fernández, Carmen De la Fuente-Martos, Rafael Ruiz-Montero, Bernardo R Guzmán-Herrador, Rafael León-López, Francisco Javier Gómez, Julia Guzmán-Puche, Luis Martínez-Martínez, Inmaculada Salcedo-Leal

Registry-linked trialAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05983861 (Risk Factors for Multidrug Resistant Bacteria at ICU Admission), which is not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05983861 unknown statusnot on this mapstarted 2023, after this paper: background citation

Risk Factors for Multidrug Resistant Bacteria at ICU Admission

TypeobservationalSponsorJosé Raimundo Araujo de AzevedoRan2023 to 2025Enrolled400ConditionsMulti Drug Resistant BacteriaArmsIdentification o Multi Drug Resistant Bacteria
3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Challenges and opportunities in the management of severe pneumonia. Key concepts from the Seventh Annual Meeting of Spanish Experts 2025.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Therapeutic management of health care-associated pneumonia.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2025
    Review
  7. Article
  8. Article
  9. Evaluation of Infections Caused by Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2025
    Article
  10. Article
  11. Review
  12. Review
  13. Multidrug-Resistant Bacteria in Immunocompromised Patients.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. [Multiple PCRRevista espanola de salud publica · 2023
    Observational
  19. Review
  20. Antimicrobial stewardship in the intensive care unit.Journal of intensive medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nicolás Francisco Fernández-MartínezPreventive Medicine and Public Health Unit, Reina Sofía University Hospital, 14004 Córdoba, Spain.ORCID 0000-0001-8257-4304
Sheila Cárcel-FernándezMaimonides Biomedical Research Institute of Cordoba (IMIBIC), 14004 Córdoba, Spain.ORCID 0000-0003-0548-4262
Carmen De la Fuente-MartosMaimonides Biomedical Research Institute of Cordoba (IMIBIC), 14004 Córdoba, Spain.
Rafael Ruiz-MonteroPreventive Medicine and Public Health Unit, Reina Sofía University Hospital, 14004 Córdoba, Spain.ORCID 0000-0002-9113-6493
Bernardo R Guzmán-HerradorPreventive Medicine and Public Health Unit, Reina Sofía University Hospital, 14004 Córdoba, Spain.
Rafael León-LópezMaimonides Biomedical Research Institute of Cordoba (IMIBIC), 14004 Córdoba, Spain.ORCID 0000-0002-8102-9520
Francisco Javier GómezDepartment of Medicine, University of Granada, 18011 Granada, Spain.
Julia Guzmán-PucheMaimonides Biomedical Research Institute of Cordoba (IMIBIC), 14004 Córdoba, Spain.
Luis Martínez-MartínezMaimonides Biomedical Research Institute of Cordoba (IMIBIC), 14004 Córdoba, Spain.ORCID 0000-0002-6091-4045
Inmaculada Salcedo-LealPreventive Medicine and Public Health Unit, Reina Sofía University Hospital, 14004 Córdoba, Spain.ORCID 0000-0002-0864-6856

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multidrug-resistant Gram-negative bacteria (MDR-GNB) are microorganisms that have acquired resistance to extended-spectrum antibacterials and constitute an emerging threat to public health. Although carriers are an important source of transmission in healthcare settings, data about risk factors for MDR-GNB carriage are limited. Therefore, we aimed to identify risk factors for MDR-GNB carriage upon intensive care unit (ICU) admission and to optimise screening strategies. We conducted a case-control study. Admissions of adult patients to the ICU of a 1000-bed hospital during a year were included. We collected sociodemographic, clinical and microbiological data and performed a multivariate logistic regression model. A total of 1342 patients resulted in 1476 episodes of ICU admission, 91 (6.2%) of whom harboured MDR-GNB (38.5% women; median age 63.9 years). The most frequently isolated pathogens were

Indexed as

Cross InfectionGram-Negative Bacterial InfectionsAdultAnti-Bacterial AgentsCase-Control StudiesDrug Resistance, Multiple, BacterialFemaleGram-Negative BacteriaHumansIntensive Care UnitsMaleMiddle AgedRisk FactorsAnti-Bacterial Agentsantibacterial drug resistancecritical careepidemiologygram negative bacteriainfection controlrisk factors

Identifiers

PMID35162062
PMCPMC8834020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.